Evidence map›Paper›PMID 38727354›Full record

ArticleNanomaterials (Basel, Switzerland)2024

Graphene Oxide (GO)-Based Bioink with Enhanced 3D Printability and Mechanical Properties for Tissue Engineering Applications.

Katarzyna Kosowska, Paulina Korycka, Kamila Jankowska-Snopkiewicz, Joanna Gierałtowska, Milena Czajka, Katarzyna Florys-Jankowska, Magdalena Dec, Agnieszka Romanik-Chruścielewska, Maciej Małecki, Kinga Westphal and 2 more

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. MXene Bioinks for 3D Bioprinting: Design and Translation.Small (Weinheim an der Bergstrasse, Germany) · 2026
    Review
  2. Article
  3. Graphene and TiACS applied bio materials · 2026
    Article
  4. Bioprinting for craniofacial reconstruction: A review of advancements, clinical use, and challenges.Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery · 2025
    Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Katarzyna KosowskaFoundation of Research and Science Development, 01-793 Warsaw, Poland.ORCID 0000-0001-5914-6176
Paulina KoryckaFoundation of Research and Science Development, 01-793 Warsaw, Poland.
Kamila Jankowska-SnopkiewiczFoundation of Research and Science Development, 01-793 Warsaw, Poland.
Joanna GierałtowskaFoundation of Research and Science Development, 01-793 Warsaw, Poland.
Milena CzajkaFoundation of Research and Science Development, 01-793 Warsaw, Poland.ORCID 0000-0001-5791-643X
Katarzyna Florys-JankowskaFoundation of Research and Science Development, 01-793 Warsaw, Poland.
Magdalena DecFoundation of Research and Science Development, 01-793 Warsaw, Poland.
Agnieszka Romanik-ChruścielewskaFoundation of Research and Science Development, 01-793 Warsaw, Poland.
Maciej MałeckiDepartment of Applied Pharmacy, Faculty of Pharmacy, Medical University of Warsaw, 1 Banacha Street, 02-097 Warsaw, Poland.ORCID 0000-0002-7078-4918
Kinga WestphalFoundation of Research and Science Development, 01-793 Warsaw, Poland.
Michał WszołaFoundation of Research and Science Development, 01-793 Warsaw, Poland.
Marta KlakFoundation of Research and Science Development, 01-793 Warsaw, Poland.ORCID 0000-0003-3901-586X

Funding

National Centre for Research and Development TECHMATSTRATEG-III/0027/2019-00/Narodowe Centrum Badan i Rozwoju
6 · The paper itself

Abstract

Currently, a major challenge in material engineering is to develop a cell-safe biomaterial with significant utility in processing technology such as 3D bioprinting. The main goal of this work was to optimize the composition of a new graphene oxide (GO)-based bioink containing additional extracellular matrix (ECM) with unique properties that may find application in 3D bioprinting of biomimetic scaffolds. The experimental work evaluated functional properties such as viscosity and complex modulus, printability, mechanical strength, elasticity, degradation and absorbability, as well as biological properties such as cytotoxicity and cell response after exposure to a biomaterial. The findings demonstrated that the inclusion of GO had no substantial impact on the rheological properties and printability, but it did enhance the mechanical properties. This enhancement is crucial for the advancement of 3D scaffolds that are resilient to deformation and promote their utilization in tissue engineering investigations. Furthermore, GO-based hydrogels exhibited much greater swelling, absorbability and degradation compared to non-GO-based bioink. Additionally, these biomaterials showed lower cytotoxicity. Due to its properties, it is recommended to use bioink containing GO for bioprinting functional tissue models with the vascular system, e.g., for testing drugs or hard tissue models.

Indexed as

bioinkbioprintingextracellular matrixgraphene oxidetissue engineering

Identifiers

PMID38727354
PMCPMC11085087

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.